Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 7
2018 9
2019 16
2020 16
2021 17
2022 15
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

71 results
Results by year
Filters applied: . Clear all
Page 1
Idiopathic pulmonary fibrosis: Disease mechanisms and drug development.
Spagnolo P, Kropski JA, Jones MG, Lee JS, Rossi G, Karampitsakos T, Maher TM, Tzouvelekis A, Ryerson CJ. Spagnolo P, et al. Among authors: karampitsakos t. Pharmacol Ther. 2021 Jun;222:107798. doi: 10.1016/j.pharmthera.2020.107798. Epub 2020 Dec 24. Pharmacol Ther. 2021. PMID: 33359599 Free PMC article. Review.
Pulmonary adverse events following immune checkpoint inhibitors.
Spagnolo P, Chaudhuri N, Bernardinello N, Karampitsakos T, Sampsonas F, Tzouvelekis A. Spagnolo P, et al. Among authors: karampitsakos t. Curr Opin Pulm Med. 2022 Sep 1;28(5):391-398. doi: 10.1097/MCP.0000000000000895. Epub 2022 Jul 16. Curr Opin Pulm Med. 2022. PMID: 35838354 Review.
Measles pneumonitis.
Schoini P, Karampitsakos T, Avdikou M, Athanasopoulou A, Tsoukalas G, Tzouvelekis A. Schoini P, et al. Among authors: karampitsakos t. Adv Respir Med. 2019;87(1):63-67. doi: 10.5603/ARM.a2019.0010. Epub 2019 Mar 4. Adv Respir Med. 2019. PMID: 30830960 Free article.
Biologic Treatments in Interstitial Lung Diseases.
Karampitsakos T, Vraka A, Bouros D, Liossis SN, Tzouvelekis A. Karampitsakos T, et al. Front Med (Lausanne). 2019 Mar 13;6:41. doi: 10.3389/fmed.2019.00041. eCollection 2019. Front Med (Lausanne). 2019. PMID: 30931306 Free PMC article. Review.
Metabolic Disorders in Chronic Lung Diseases.
Papaioannou O, Karampitsakos T, Barbayianni I, Chrysikos S, Xylourgidis N, Tzilas V, Bouros D, Aidinis V, Tzouvelekis A. Papaioannou O, et al. Among authors: karampitsakos t. Front Med (Lausanne). 2018 Jan 18;4:246. doi: 10.3389/fmed.2017.00246. eCollection 2017. Front Med (Lausanne). 2018. PMID: 29404325 Free PMC article. Review.
Infliximab-induced interstitial lung disease.
Karampitsakos T, Papaioannou O, Sampsonas F, Tzouvelekis A. Karampitsakos T, et al. BMJ Case Rep. 2021 Oct 13;14(10):e245726. doi: 10.1136/bcr-2021-245726. BMJ Case Rep. 2021. PMID: 34645638
Fanconi syndrome-associated interstitial lung disease.
Papaioannou O, Karampitsakos T, Sampsonas F, Tzouvelekis A. Papaioannou O, et al. Among authors: karampitsakos t. BMJ Case Rep. 2022 Jul 4;15(7):e249242. doi: 10.1136/bcr-2022-249242. BMJ Case Rep. 2022. PMID: 35787496
Interstitial Lung Diseases and the Impact of Gender.
Karampitsakos T, Papaioannou O, Katsaras M, Sampsonas F, Tzouvelekis A. Karampitsakos T, et al. Clin Chest Med. 2021 Sep;42(3):531-541. doi: 10.1016/j.ccm.2021.04.011. Clin Chest Med. 2021. PMID: 34353457 Review.
71 results